{"id":"https://genegraph.clinicalgenome.org/r/75e3a8fc-a2ab-4f28-917f-9b79876945bbv1.1","type":"EvidenceStrengthAssertion","dc:description":"*PGAP3* was first reported in relation to autosomal recessive hyperphosphatasia with intellectual disability syndrome 4 in 2014 (Howard et al., PMID: 24439110). Common phenotypes in individuals with *PGAP3* pathogenic variants include severe global developmental delay, speech and language delay, intellectual disability, hypotonia, ataxia, seizures, distinct facial abnormalities (including broad nasal bridge and tip, short nose, long palpebral fissures, hypertelorism, long philtrum, thin and wide upper lip, large ear lobes, and full cheeks), autistic behaviour and sleep disturbances. Additionally, some patients exhibit cleft palate and microcephaly, decreased intrauterine fetal movements, cardiac problems, abnormal corpus callosum, and olfactory bulb agenesis. \n\nNineteen homozygous and compound heterozygous variants (13 missense, 1 splicing, 2 frameshift, 2 nonsense, and 1 UTR), reported in seven publications have been included in this curation (PMIDs: 24439110, 27120253, 29531774, 30217754, 30345601, 32726939, 32845056). The presumed mechanism of pathogenicity based on published evidence is loss of function whereby variants in the *PGAP3* gene lead to a reduction in functional GPI-anchored proteins. This gene-disease relationship is also supported by a zebrafish animal model and protein interaction data (Da'as et al., 2020, PMID: 32726939; Castillon et al., 2013, PMID: 23615438).\n\nIn summary, there is definitive evidence supporting the relationship between *PGAP3* and autosomal recessive hyperphosphatasia with intellectual disability syndrome 4. This has been repeatedly demonstrated in both the research and clinical diagnostic settings. This classification was approved by the Intellectual Disability and Autism Gene Curation Expert Panel on the meeting date September 5, 2023 (SOP Version 9).\n\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/75e3a8fc-a2ab-4f28-917f-9b79876945bb","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c63978db-fe31-489a-985c-6b353f0d5243","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:classificationChange"},{"id":"cg:summaryChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c63978db-fe31-489a-985c-6b353f0d5243_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2023-09-05T06:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/c63978db-fe31-489a-985c-6b353f0d5243_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2024-02-21T16:34:13.506Z","role":"Publisher"}],"curationReasons":["ErrorClarification","NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c63978db-fe31-489a-985c-6b353f0d5243_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ca9bd53-fb21-450b-a535-d730c68537e1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ca9bd53-fb21-450b-a535-d730c68537e1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","rdfs:label":"Knaus_FamilyE_II-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":16,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d4596937-18a8-4e42-930b-4d32674011d5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.845A>G (p.Asp282Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353575"}},"detectionMethod":"cDNA/ high-throughput sequencing, Sanger sequencing \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypeFreeText":"Global developmental delay, mental delay,  limited Speech and language development, hypotonia, seizures, Sleep disturbance, Ataxia, sensorineural hearing loss, Broad nasal  tip, Tented upper lip vermilion, Broad finger and toenails, Serum total ALP (U/l) 807\n","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/92e4693f-ea9c-4b35-9078-ad40780a6cac_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4596937-18a8-4e42-930b-4d32674011d5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/92e4693f-ea9c-4b35-9078-ad40780a6cac","type":"EvidenceLine","dc:description":"Downgraded so that the functional evidence is only counted once","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92e4693f-ea9c-4b35-9078-ad40780a6cac_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/92e4693f-ea9c-4b35-9078-ad40780a6cac_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Flow cytometric analysis of patient cells showed that this missense mutation caused the decreased activity of PGAP3. Immunoprecipitation studies showed protein expression D282G was significantly reduced compared to the WT \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5271adb5-2c4b-4f63-99ac-c62515cb0dcd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5271adb5-2c4b-4f63-99ac-c62515cb0dcd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32845056","rdfs:label":"Bezuidenhout _ Patient 1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/63caccaf-2f97-44e1-935d-fb226240d54f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.557G>C (p.Arg186Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399321616"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"At birth: cleft soft palate,mild dysmorphic features notably mild hypertelorism and a prominent nose with wide nasal bridge, broad nasal tip, relative macrocephaly. 10mo; hypotonia, bilateral hyperintense small cystic lesions in the peritrigonal area, general cerebral white matter loss and a thin corpus callosum, global developmental delay, severe intellectual disability, absent speech, seizures. 2y/o; hypertelorism, long palpebral fissures, wide nasal bridge and broad tip, tented upper lip vermilion, full cheeks, and low-set ear, 97th percentile head circumference, 945 U/L ALP","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/01064bbf-8dc3-43e4-bb33-e08bbb36f68e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32845056","allele":{"id":"https://genegraph.clinicalgenome.org/r/63caccaf-2f97-44e1-935d-fb226240d54f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/01064bbf-8dc3-43e4-bb33-e08bbb36f68e","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01064bbf-8dc3-43e4-bb33-e08bbb36f68e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/a404fb57-54f1-4c76-8471-81cbcfc4f4fe_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a404fb57-54f1-4c76-8471-81cbcfc4f4fe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32845056","rdfs:label":"Bezuidenhout _ Patient 2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/63caccaf-2f97-44e1-935d-fb226240d54f"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"2y; global developmental delay, dysmorphism, hypotonic with coarse facial features, long palpebral fissures, sparse lateral eyebrows, broad nasal tip, a very high arched palate, 97th percentile body mass. 6y/o; hypertelorism, long palpebral fissures, wide nasal bridge and broad tip, tented upper lip vermillion, full cheeks, global dev delay, severe intellectual disability, absent speech, hypotonia without independent ambulation,  1,054 U/L ALP \n","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/509d573c-4974-49b6-a0d3-2bac05a1cee4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32845056","allele":{"id":"https://genegraph.clinicalgenome.org/r/63caccaf-2f97-44e1-935d-fb226240d54f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/509d573c-4974-49b6-a0d3-2bac05a1cee4","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/509d573c-4974-49b6-a0d3-2bac05a1cee4_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/c63978db-fe31-489a-985c-6b353f0d5243_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f1af714-75f7-4447-9afe-1246b32dffe6_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","rdfs:label":"Knaus_Family E","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/6f1af714-75f7-4447-9afe-1246b32dffe6","type":"Family","rdfs:label":"Knaus_Family E","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9ca9bd53-fb21-450b-a535-d730c68537e1"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Global developmental delay, mental delay,  limited Speech and language development, hypotonia, seizures, Sleep disturbance, Ataxia, sensorineural hearing loss, Broad nasal  tip, Tented upper lip vermilion, Broad finger and toenails, Serum total ALP (U/l) 807\n","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/9ca9bd53-fb21-450b-a535-d730c68537e1"}},{"id":"https://genegraph.clinicalgenome.org/r/db8ffd77-1e49-4205-a197-3c4020cec10a_proband_segregation","type":"FamilyCosegregation","dc:description":"Autozygosity mapping and exome sequencing identified a 13.8 Mb region harboring a homozygous c.275G>A (p.Gly92Asp) variant in PGAP3 region 17q11.2–q21.32. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24439110","rdfs:label":"Howard _ Family A","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/db8ffd77-1e49-4205-a197-3c4020cec10a","type":"Family","rdfs:label":"Howard _ Family A","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/97d9a8d2-2e08-49f5-9620-24bbfd1e240a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24439110","rdfs:label":"Family A_V2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1729df5d-7928-4770-ab2c-9d173950396e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.275G>A (p.Gly92Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA150828"}},"detectionMethod":"autozygosity mapping, exome sequencing, sanger sequencing\n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypeFreeText":"Involuntary midline hand movements, bruxism, serum total ALP (U/l) 1407","phenotypes":["obo:HP_0000431","obo:HP_0002265","obo:HP_0000316","obo:HP_0010804","obo:HP_0001252","obo:HP_0001270","obo:HP_0000175","obo:HP_0000582","obo:HP_0003196","obo:HP_0032795","obo:HP_0004379","obo:HP_0001263"],"previousTesting":false,"secondTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e7a0e8aa-0631-4f3b-b673-46ae8abdd9d4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24439110","allele":{"id":"https://genegraph.clinicalgenome.org/r/1729df5d-7928-4770-ab2c-9d173950396e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Involuntary midline hand movements, bruxism, serum total ALP (U/l) 1407","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000431","obo:HP_0003196","obo:HP_0001252","obo:HP_0032795","obo:HP_0001263","obo:HP_0000316","obo:HP_0002265","obo:HP_0004379","obo:HP_0000582","obo:HP_0000175","obo:HP_0010804","obo:HP_0001270"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/97d9a8d2-2e08-49f5-9620-24bbfd1e240a"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/767b2ebb-294d-427a-90eb-c12881f5e5c5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","rdfs:label":"Knaus_Family C","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/767b2ebb-294d-427a-90eb-c12881f5e5c5","type":"Family","rdfs:label":"Knaus_Family C","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/2e42ab21-f879-47e8-86a2-929ef1a0c793","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","rdfs:label":"Knaus_FamilyC_II-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/bc15491f-efe2-4b2b-8c6a-987eec119d1a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.861G>T (p.Trp287Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353573"}},"detectionMethod":"cDNA/ high-throughput sequencing, Sanger sequencing \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypeFreeText":"Serum total ALP (U/l)  830–1,000","phenotypes":["obo:HP_0001251","obo:HP_0000657","obo:HP_0001344","obo:HP_0012758","obo:HP_0001263","obo:HP_0004379","obo:HP_0010804","obo:HP_0032795"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3efccb3f-5783-4a4a-a3a2-0a45c22fc033_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","allele":{"id":"https://genegraph.clinicalgenome.org/r/bc15491f-efe2-4b2b-8c6a-987eec119d1a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Serum total ALP (U/l)  830–1,000","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0010804","obo:HP_0000657","obo:HP_0001263","obo:HP_0001251","obo:HP_0001344","obo:HP_0012758","obo:HP_0032795","obo:HP_0004379"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2e42ab21-f879-47e8-86a2-929ef1a0c793"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4f986148-9f1c-49ce-870b-a39cf90a2f3e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f986148-9f1c-49ce-870b-a39cf90a2f3e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","rdfs:label":"Knaus _ Family D_ II-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":23,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/86d8c566-759b-41ae-8cb5-5b0ff97d671b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.320C>T (p.Ser107Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351381"}},{"id":"https://genegraph.clinicalgenome.org/r/360c17a0-a9c2-4044-a88b-e07490f8ca1a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.914A>G (p.Asp305Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA150829"}}],"detectionMethod":"cDNA/ high-throughput sequencing, Sanger sequencing \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypeFreeText":"Serum total ALP (U/l) 300–738 ","phenotypes":["obo:HP_0001344","obo:HP_0002566","obo:HP_0012758","obo:HP_0000175","obo:HP_0001263","obo:HP_0002019","obo:HP_0001837","obo:HP_0002317","obo:HP_0000712","obo:HP_0000717","obo:HP_0012811","obo:HP_0002265","obo:HP_0010804","obo:HP_0000455"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0978cb3f-f168-4a9a-958b-b4612b2b135b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","allele":{"id":"https://genegraph.clinicalgenome.org/r/360c17a0-a9c2-4044-a88b-e07490f8ca1a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/5e5accd0-8fab-4c7f-95e4-21f6735e0d85_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","allele":{"id":"https://genegraph.clinicalgenome.org/r/86d8c566-759b-41ae-8cb5-5b0ff97d671b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/0978cb3f-f168-4a9a-958b-b4612b2b135b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0978cb3f-f168-4a9a-958b-b4612b2b135b_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5e5accd0-8fab-4c7f-95e4-21f6735e0d85","type":"EvidenceLine","dc:description":"Downgraded because the variant functional study is scored in family A","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e5accd0-8fab-4c7f-95e4-21f6735e0d85_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5e5accd0-8fab-4c7f-95e4-21f6735e0d85_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Flow cytometric analysis of patient cells showed that this missense mutations caused the decreased activity of PGAP3. Immunoprecipitation studies showed protein expression S107L was significantly reduced compared to the WT \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/6acf735c-ec8c-41b6-9764-549f8cf8222d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6acf735c-ec8c-41b6-9764-549f8cf8222d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32726939","rdfs:label":"Da'as _ III-1","ageType":"AgeAtReport","ageUnit":"Months","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b12a4b27-50c3-4267-acd3-87b88dff962a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.265C>T (p.Gln89Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399261105"}},"detectionMethod":"WGS","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"cleft palate, hypotonia, stereotypy (rhythmic, repetitive hand movements), upper lid blepharoptosis with compensatory frontalis hyperactivity, occipital plagiocephaly (postural molding), intermittent habitual tongue thrusting, and mild ear asymmetry (left ear with relative conchal bowl hypertrophy), gross motor delay and a complete lack of speech acquisition, developmental delay, (ALP) (730 IU/L), poor vision, GERD\n","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5a8a0cca-542f-456b-bd7f-5500029ef172_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32726939","allele":{"id":"https://genegraph.clinicalgenome.org/r/b12a4b27-50c3-4267-acd3-87b88dff962a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/5a8a0cca-542f-456b-bd7f-5500029ef172","type":"EvidenceLine","dc:description":"Per ID/A guidelines, no proband is scored over 2 points.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a8a0cca-542f-456b-bd7f-5500029ef172_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/97d9a8d2-2e08-49f5-9620-24bbfd1e240a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97d9a8d2-2e08-49f5-9620-24bbfd1e240a"},{"id":"https://genegraph.clinicalgenome.org/r/e7a0e8aa-0631-4f3b-b673-46ae8abdd9d4","type":"EvidenceLine","dc:description":"Downgraded so that the functional evidence is only counted once","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7a0e8aa-0631-4f3b-b673-46ae8abdd9d4_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e7a0e8aa-0631-4f3b-b673-46ae8abdd9d4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional expression studies in CHO cells showed that the mutant G92D protein had almost no or absent enzyme activity. Electrophoresis and immunoblotting studies showed that the G92D protein was full-sized, had normally matured N-glycan, and localized to the Golgi, similar to wild type. \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a27910a8-5b01-4d02-aa0d-884ed242ef7b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a27910a8-5b01-4d02-aa0d-884ed242ef7b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24439110","rdfs:label":"Howard_Family C_II-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5fa9e717-057d-46c3-b2ef-d3ef56191d4d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.314C>G (p.Pro105Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA150831"}},"detectionMethod":"Target Seq","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypeFreeText":"Serum total ALP (U/l) 928-1370","phenotypes":["obo:HP_0001263","obo:HP_0032795","obo:HP_0010804","obo:HP_0001252","obo:HP_0001270","obo:HP_0004379","obo:HP_0003155","obo:HP_0003196","obo:HP_0000316","obo:HP_0000431"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5cb3248a-a3e0-4225-96cd-60876ccaad1b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24439110","allele":{"id":"https://genegraph.clinicalgenome.org/r/5fa9e717-057d-46c3-b2ef-d3ef56191d4d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/5cb3248a-a3e0-4225-96cd-60876ccaad1b","type":"EvidenceLine","dc:description":"Downgraded so that the functional evidence is only counted once ","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5cb3248a-a3e0-4225-96cd-60876ccaad1b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5cb3248a-a3e0-4225-96cd-60876ccaad1b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In vitro functional expression studies in CHO cells showed that the mutant P105R protein had low residual enzyme activity. Electrophoresis and immunoblotting studies showed that the P105R protein had only immature ER-form N-glycan and did not localize properly to the Golgi, but was retained in the ER","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/24c99b52-1203-499a-9a0b-465d0214e15e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24c99b52-1203-499a-9a0b-465d0214e15e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","rdfs:label":"Knaus _ Family F_ II-3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/bffd8068-a6ff-4deb-b8b4-791862b426fe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.511T>C (p.Cys171Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353586"}},{"id":"https://genegraph.clinicalgenome.org/r/859c9cc8-39b5-4c3d-8bb7-39228060652e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.842T>C (p.Leu281Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353594"}}],"detectionMethod":"cDNA/ high-throughput sequencing, Sanger sequencing \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypeFreeText":"severe food allergy, eczema, Serum total ALP (U/l) 1,848–5,275\n","phenotypes":["obo:HP_0009748","obo:HP_0001344","obo:HP_0001252","obo:HP_0000407","obo:HP_0004379","obo:HP_0012758","obo:HP_0002019","obo:HP_0000175","obo:HP_0002360","obo:HP_0001263","obo:HP_0001251"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/7af6c9f3-0d5c-4037-a246-20257d71bcb3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","allele":{"id":"https://genegraph.clinicalgenome.org/r/859c9cc8-39b5-4c3d-8bb7-39228060652e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/6bafdb42-4d74-4184-83f8-850afc9786f5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","allele":{"id":"https://genegraph.clinicalgenome.org/r/bffd8068-a6ff-4deb-b8b4-791862b426fe"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/6bafdb42-4d74-4184-83f8-850afc9786f5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6bafdb42-4d74-4184-83f8-850afc9786f5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/6bafdb42-4d74-4184-83f8-850afc9786f5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Flow cytometric analysis of patient cells showed that this missense mutation, C171R caused the decreased activity of PGAP3. Immunoprecipitation studies showed protein expression C171R was significantly reduced compared to the WT \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7af6c9f3-0d5c-4037-a246-20257d71bcb3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7af6c9f3-0d5c-4037-a246-20257d71bcb3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/7af6c9f3-0d5c-4037-a246-20257d71bcb3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Immunoprecipitation studies showed protein expression L281P was significantly reduced compared to the WT \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/4548e9e5-aa93-4a83-95a6-1631623970b5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4548e9e5-aa93-4a83-95a6-1631623970b5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","rdfs:label":"Knaus _ Family B_ II-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/fcd1aa4a-2bdd-4583-a978-b6e9042c7ac9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.402dup (p.Met135HisfsTer28)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353566"}},{"id":"https://genegraph.clinicalgenome.org/r/045b7601-3bb8-4790-8f81-4d1313940ecc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.558-10G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351384"}}],"detectionMethod":"cDNA/ high-throughput sequencing, Sanger sequencing \n","firstTestingMethod":"Other","phenotypeFreeText":"small teeth, serum total ALP (U/l) 333","phenotypes":["obo:HP_0000188","obo:HP_0032795","obo:HP_0004379","obo:HP_0001251","obo:HP_0012811","obo:HP_0012758","obo:HP_0001837","obo:HP_0001276","obo:HP_0000455","obo:HP_0001500","obo:HP_0001344","obo:HP_0010804","obo:HP_0000717","obo:HP_0001263","obo:HP_0000582"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/01249997-e93c-4899-86e6-f30ddfad642a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","allele":{"id":"https://genegraph.clinicalgenome.org/r/fcd1aa4a-2bdd-4583-a978-b6e9042c7ac9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/8b8837f2-f2bc-4024-b925-10736b97d7ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","allele":{"id":"https://genegraph.clinicalgenome.org/r/045b7601-3bb8-4790-8f81-4d1313940ecc"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/8b8837f2-f2bc-4024-b925-10736b97d7ae","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b8837f2-f2bc-4024-b925-10736b97d7ae_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/01249997-e93c-4899-86e6-f30ddfad642a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01249997-e93c-4899-86e6-f30ddfad642a_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/17f4286a-14c6-4a09-87ea-7c1cb5f0be4c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17f4286a-14c6-4a09-87ea-7c1cb5f0be4c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32845056","rdfs:label":"Bezuidenhout _ Patient 3","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/63caccaf-2f97-44e1-935d-fb226240d54f"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"At birth; soft palate, hypotonia, macrocephaly, mild facial dysmorphism of hypertelorism, low set ears. 1y 2mo; single prolonged focal seizure, Dandy-walker variant comprising a persistent Blake's pouch cyst. 1y 10mo;  hypertelorism, long palpebral fissures, wide nasal bridge, broad nasal tip, tented upper lip vermilion, full cheeks, low set ears 958 U/L ALP\n","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9c4ae4e8-342b-486a-97b3-200bf66e1522_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32845056","allele":{"id":"https://genegraph.clinicalgenome.org/r/63caccaf-2f97-44e1-935d-fb226240d54f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/9c4ae4e8-342b-486a-97b3-200bf66e1522","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c4ae4e8-342b-486a-97b3-200bf66e1522_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/98a392f0-4ded-4c18-82cf-fcf84d9f8d6c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98a392f0-4ded-4c18-82cf-fcf84d9f8d6c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30217754","rdfs:label":"Akgün Doğan _ Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":54,"allele":{"id":"https://genegraph.clinicalgenome.org/r/60623ba4-be80-4632-ae4f-0c3bb81887a0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.507C>A (p.Tyr169Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399321754"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Tented Thin Upper Lip, Broad Nasal Bridge, Hypertelorism, Large Fleshy Ear Lobes, Short Upturned Nose, Cleft Palate, Upslanted Palpebral Fissures, Long Philtrum, Brachycephaly, Large Anterior Fontanel Size, Postnatal Microcephaly, Short Stature, Global Developmental Delay Hypotonia, Thin/Dysgenetic Corpus Callosum, Mild Ventriculomegaly, Frontoparietal Atrophy, Dysphagia, patent foramen ovale, Brittle/Hypoplastic Nails, Thin/Sparse Hair, Inguinal,  Hernia, Intestinal Malrotation, Ear Pit, Nystagmus, ALP levels (U/L) 672–837\n","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b3e9757a-3b6d-48d7-87e6-1caa71525e4b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30217754","allele":{"id":"https://genegraph.clinicalgenome.org/r/60623ba4-be80-4632-ae4f-0c3bb81887a0"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/b3e9757a-3b6d-48d7-87e6-1caa71525e4b","type":"EvidenceLine","dc:description":"Per ID/A guidelines, no proband is scored over 2 points.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3e9757a-3b6d-48d7-87e6-1caa71525e4b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a1d616cd-186b-4c66-9249-968df74f636e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1d616cd-186b-4c66-9249-968df74f636e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","rdfs:label":"Knaus _ Family A_ II-1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":25,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/045b7601-3bb8-4790-8f81-4d1313940ecc"},{"id":"https://genegraph.clinicalgenome.org/r/86d8c566-759b-41ae-8cb5-5b0ff97d671b"}],"detectionMethod":"cDNA/ high-throughput sequencing, sanger sequencing \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypeFreeText":"Serum total ALP (U/l) 469","phenotypes":["obo:HP_0032795","obo:HP_0012811","obo:HP_0001344","obo:HP_0012758","obo:HP_0000175","obo:HP_0002360","obo:HP_0000717","obo:HP_0004379","obo:HP_0000582","obo:HP_0010804","obo:HP_0001263","obo:HP_0000718"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0195e072-514a-4b04-8196-acc14269f1ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","allele":{"id":"https://genegraph.clinicalgenome.org/r/86d8c566-759b-41ae-8cb5-5b0ff97d671b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/caed68db-93b5-41a8-96f8-ebff0f541b7b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27120253","allele":{"id":"https://genegraph.clinicalgenome.org/r/045b7601-3bb8-4790-8f81-4d1313940ecc"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/caed68db-93b5-41a8-96f8-ebff0f541b7b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/caed68db-93b5-41a8-96f8-ebff0f541b7b_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0195e072-514a-4b04-8196-acc14269f1ad","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0195e072-514a-4b04-8196-acc14269f1ad_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0195e072-514a-4b04-8196-acc14269f1ad_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Flow cytometric analysis of patient cells showed that this missense mutation(S107L) caused the decreased activity of PGAP3. Immunoprecipitation study showed protein expression S107L was significantly reduced compared to the WT\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/a3460a65-3bca-41c1-86ea-0d2badd0a2d1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3460a65-3bca-41c1-86ea-0d2badd0a2d1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24439110","rdfs:label":"Howard _ Family B  _ II-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/adc2b4b1-5672-4bdb-b592-6ba81646e6a1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.439dup (p.Leu147ProfsTer16)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353567"}},{"id":"https://genegraph.clinicalgenome.org/r/360c17a0-a9c2-4044-a88b-e07490f8ca1a"}],"detectionMethod":"Target Seq","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypeFreeText":"Serum total ALP (U/l) 926-2000","phenotypes":["obo:HP_0003196","obo:HP_0004379","obo:HP_0001263","obo:HP_0001270","obo:HP_0001252","obo:HP_0010804","obo:HP_0032795","obo:HP_0003155","obo:HP_0000316","obo:HP_0000431"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b648b4c9-fe33-4880-a4fe-1170b75916af_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24439110","allele":{"id":"https://genegraph.clinicalgenome.org/r/360c17a0-a9c2-4044-a88b-e07490f8ca1a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/616e9fe1-92e0-4b4e-b441-fa25ca3cb481_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24439110","allele":{"id":"https://genegraph.clinicalgenome.org/r/adc2b4b1-5672-4bdb-b592-6ba81646e6a1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/b648b4c9-fe33-4880-a4fe-1170b75916af","type":"EvidenceLine","dc:description":"Per ID/A guidelines, no proband is scored over 2 points.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b648b4c9-fe33-4880-a4fe-1170b75916af_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b648b4c9-fe33-4880-a4fe-1170b75916af_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression studies in CHO cells showed that the mutant D305G protein had some residual enzyme activity. Electrophoresis and immunoblotting studies showed that the mutant protein had only immature ER-form N-glycan and did not localize properly to the Golgi, but was retained in the ER. Flow cytometric analysis of patient cells showed a reduction in the cell surface levels of GPI-anchored proteins.\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/616e9fe1-92e0-4b4e-b441-fa25ca3cb481","type":"EvidenceLine","dc:description":"Per ID/A guidelines, no proband is scored over 2 points.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/616e9fe1-92e0-4b4e-b441-fa25ca3cb481_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/616e9fe1-92e0-4b4e-b441-fa25ca3cb481_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression studies in CHO cells showed that the mutant c.439dupC cells had no residual enzyme activity, and was likely degraded by nonsense-mediated mRNA decay. \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2e42ab21-f879-47e8-86a2-929ef1a0c793_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e42ab21-f879-47e8-86a2-929ef1a0c793"},{"id":"https://genegraph.clinicalgenome.org/r/3efccb3f-5783-4a4a-a3a2-0a45c22fc033","type":"EvidenceLine","dc:description":"The proband is a compound heterozygote with the second likely pathogenic variant c.∗559C>T 3`UTR. This variant is not scored due to scoring limitations. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3efccb3f-5783-4a4a-a3a2-0a45c22fc033_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3efccb3f-5783-4a4a-a3a2-0a45c22fc033_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Flow cytometric analysis of patient cells showed that this missense mutation caused the decreased activity of PGAP3. Immunoprecipitation studies showed mutant protein expression was significantly reduced compared to the WT. \n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/122cedba-6101-47f6-886e-8b45877f91be_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/122cedba-6101-47f6-886e-8b45877f91be","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29531774","rdfs:label":"Sakaguchi _II-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/25aa8ef9-cbe3-4fe3-a4f7-bcc110d64ddf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033419.5(PGAP3):c.314C>A (p.Pro105Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399260982"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"congenital anomalies; broad nasal bridge, tented upper lip vermilion, cleft palate, low set ears, micrognathia, retrognathia, brachytelephalangy, left sided cryptorchidism, wide feet, broad toes. Hypotonia at 2.5y, recurrent generalized seizures with dysrhythmic electroencephalographic paroxysmal changes at 3, progressive thoracic scoliosis, thin corpus callosum, at 5 y/o, severe psychomotor developmental delay, autistic behavior, bruxism, brief eye contact, cannot walk independently or speak any meaningful words at 8, 578 U/L at the age of 7.5 years, facial dysmorphism, cryptorchidism ","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ee86ee33-7e4e-43b2-bd2a-308f5d52c21b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29531774","allele":{"id":"https://genegraph.clinicalgenome.org/r/25aa8ef9-cbe3-4fe3-a4f7-bcc110d64ddf"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/ee86ee33-7e4e-43b2-bd2a-308f5d52c21b","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee86ee33-7e4e-43b2-bd2a-308f5d52c21b_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/c63978db-fe31-489a-985c-6b353f0d5243_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c63978db-fe31-489a-985c-6b353f0d5243_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14c693be-cf12-4cad-9eab-fd2350f093df","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89a39f83-d148-408c-926e-994901815ed8","type":"Finding","dc:description":"C-terminally tagged PGAP3 constructs, PGAP3-EGFP and PGAP3-HA, can be specifically co-precipitated by FLAG-tagged PGAP2. Since the amount of tagged PGAP3 that co-precipitated was low, it was not excluded that endogenous, nontagged PGAP3, interacts with PGAP2 more efficiently than C-terminally tagged PGAP3. \n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23615438","rdfs:label":"Castillon_PGAP3/2 Protein Interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c63978db-fe31-489a-985c-6b353f0d5243_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2425000-82e5-407e-8156-447b541aee88","type":"EvidenceLine","dc:description":"Downgraded for being a non-mammalian organism. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/302fbfb8-1ad9-4d68-89be-3522c5469946","type":"Finding","dc:description":"Pgap3 morphants displayed defective neural tube formation during the early stages of nervous system development, affecting brain morphogenesis. The significant abnormal midbrain and hindbrain formation demonstrated by separation of the left and right tectal ventricles, defects in the cerebellar corpus, and caudal hindbrain formation disrupted oligodendrocytes expression leading to shorter motor neurons axons. Assessment of zebrafish neuromuscular responses revealed epileptic-like movements at early development, followed by seizure-like behavior, loss of touch response, and hypotonia, mimicking the clinical phenotype human patients. These are the clinical hallmarks and developmental defects seen in HPMRS4 patients, suggesting a novel and essential role of PGAP3 at the early stages of brain development and morphogenesis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32726939","rdfs:label":"Da'as _ Zebrafish Model Organism","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Definitive","sequence":7823,"specifiedBy":"GeneValidityCriteria9","strengthScore":13.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/httnDAjKLKI","type":"GeneValidityProposition","disease":"obo:MONDO_0014318","gene":"hgnc:23719","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c63978db-fe31-489a-985c-6b353f0d5243-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}